Phio Pharmaceuticals Corp Share Price

NASDAQ: PHIO

Small Cap

$2.17

+0.04

(+1.64%)

as on September 17, 2025 at 1:29 am IST

$₹

Phio Pharmaceuticals Corp Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$2.11
Day's Price Range
$2.18
$2.17
2.76%
Downside
0.46%
Upside
52 Week's Low
52 Week's High
$0.97
52-Week Price Range
$9.79
$2.17
55.50%
Downside
351.15%
Upside

Phio Pharmaceuticals Corp share price movements today

Previous Close: $2.13
Open: $2.15
Volume: 325.4K
Day's Low - High: $2.11 - $2.18
52 Week Low - High: $0.97 - $9.79

Phio Pharmaceuticals Corp Historical Returns

1 Month Return: -2.29 %
3 Month Return: -14.11 %
1 Year Return: -35.65 %
3 Year Return: -73.9 %
5 Year Return: -91.71 %

Phio Pharmaceuticals Corp Stock Fundamentals & Key Indicators

Check Phio Pharmaceuticals Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.5M

EPS (TTM)

-1.8

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-7.4M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

83330300.00%

Phio Pharmaceuticals Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Phio Pharmaceuticals Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Phio Pharmaceuticals Corp	BUY	$12.5M	-91.71%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Phio Pharmaceuticals Corp Stock including INR - Dollar returns

The Phio Pharmaceuticals Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Phio Pharmaceuticals Corp investment value today

Current value as on today

₹70,426

Returns

₹29,574

(-29.57%)

Returns from Phio Pharmaceuticals Corp Stock

₹34,441 (-34.44%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Phio Pharmaceuticals Corp Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Phio Pharmaceuticals Corp. Average target price of $14

Phio Pharmaceuticals Corp Share Price Target

Get share price movements and forecasts by analysts on Phio Pharmaceuticals Corp.

What analysts predicted

84.5%UPSIDE

Target Price

$14

Current Price

$2.17

Analyzed by

7 Analysts

Target

$14.00

Phio Pharmaceuticals Corp target price $14, a slight upside of 84.5% compared to current price of $2.17. According to 7 analysts rating.

Phio Pharmaceuticals Corp Stock's Interest Amongst Investors

Search interest for Phio Pharmaceuticals Corp Stock has decreased by -86% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-86% versus previous 30 day period

Phio Pharmaceuticals Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	0	-	-	0	-	-
Gross Profit	0	0	0	-	0	0	0	0	-	-
Operating Income	-3	-2	-2	-1	-2	-1	-1	-1	-1	-2
EBITDA	-3	-2	-2	-	-2	-1	-1	-1	-1	-2
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	-	-	-	-
Income Before Tax	-3	-2	-2	-1	-2	-1	-1	-1	-1	-2
Income Tax Expense	0	0	0	-	0	-	-	0	-	-
Net Income	-3	-2	-2	-1	-2	-1	-1	-1	-1	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-7180.00%	0.00%	0.00%	-2322.86%	0.00%	0.00%

Phio Pharmaceuticals Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	0	0	-	-	-	-
Gross Profit	-6	-5	-5	0	0	0	0	0	-6	0
Operating Income	-10	-9	-14	-7	-8	-8	-13	-11	-10	-7
EBITDA	-10	-8	-14	-7	-8	-8	-13	-11	-10	-7
Interest Expense	-	-	0	-	-	-	0	0	-	0
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-10	-8	-14	-7	-8	-8	-13	-11	-10	-7
Income Tax Expense	0	0	-1	0	0	0	0	0	0	-7
Net Income	-10	-8	-12	-7	-8	-8	-13	-11	-10	-7
Net Profit Margin	-30067.65%	-47336.84%	-83013.33%	-5333.33%	-42100.00%	-201604.77%	0.00%	0.00%	0.00%	0.00%

Phio Pharmaceuticals Corp Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	-2	-1	-2	-1	-1	-1	-1	-2
Operating Cash Flow	-2	-2	-2	-2	-1	-1	-1	-1	-2
Investing Cash Flow	0	-	-	-	-	-	0	0	0
Financing Cash Flow	5	-	2	0	-	2	1	9	0
Change in Cash	2	-2	0	-2	-1	0	0	7	-2

Phio Pharmaceuticals Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-8	-12	-7	-8	-8	-13	-11	-10	-7
Operating Cash Flow	-7	-9	-7	-8	-8	-11	-12	-10	-7
Investing Cash Flow	5	0	0	0	0	0	0	0	0
Financing Cash Flow	10	0	18	0	16	21	0	7	3
Change in Cash	7	-9	11	-7	7	9	-12	-3	-3

Global Institutional Holdings in Phio Pharmaceuticals Corp

Funds	Holdings
Geode Capital Management, LLC	0.87%
Cetera Investment Advisers	0.8%
XTX Topco Ltd	0.23%
Morgan Stanley - Brokerage Accounts	0.12%
Tower Research Capital LLC	0.05%

See all

Insights on Phio Pharmaceuticals Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 190.4%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 106.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, PHIO stock has moved down by -12.7%

About Phio Pharmaceuticals Corp

phio pharmaceuticals corp., a biotechnology company, develops immuno-oncology therapeutics in the united states. it offers intasyl therapeutic platform focuses on silencing tumor-induced suppression of the immune system. the company develops ph-762 which targets the checkpoint protein pd-1 on immune cells for used in adoptive cell transfer (act); ph-804 that targets the suppressive immune receptor tigit, which is a checkpoint protein present on t cells and natural killer cells for used in act; and ph-790 which targets pd-l1 protein that keeps immune cells from attacking nonharmful cells in the body. it has collaborations with the gustave roussy and medigene ag, as well as with helmholtz zentrum mã¼nchen. the company was formerly known as rxi pharmaceuticals corporation and changed its name to phio pharmaceuticals corp. in november 2018. phio pharmaceuticals corp. was incorporated in 2011 and is headquartered in marlborough, massachusetts.

Organisation	Phio Pharmaceuticals Corp
Headquarters	11 Apex Drive, Marlborough, MA, United States, 01752
Industry	Health Technology
CEO	Mr. Robert J. Bitterman
E-voting on shares	Click here to vote

Key Management of Phio Pharmaceuticals Corp

Name	Title
Mr. Robert J. Bitterman	President, CEO & Chairman
Ms. Lisa Carson	Principal Financial Officer, Principal Accounting Officer and VP of Finance & Administration
Ms. Linda M. Mahoney	Senior Vice President of Development

FAQs

What is Phio Pharmaceuticals Corp share price today?

Phio Pharmaceuticals Corp share price today is $2.17 as on September 17, 2025 at 1:29 am IST at the close of the market. Phio Pharmaceuticals Corp share today touched a day high of $2.18 and a low of $2.11.

What is the 52 week high and 52 week low for Phio Pharmaceuticals Corp share?

Phio Pharmaceuticals Corp share touched a 52 week high of $9.79 on January 13, 2025 and a 52 week low of $0.97 on April 8, 2025. Phio Pharmaceuticals Corp stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $2.17,which is 77.83% down from its 52 week high and 124.71% up from its 52 week low.

What is Phio Pharmaceuticals Corp's market capitalisation today?

Phio Pharmaceuticals Corp market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Phio Pharmaceuticals Corp Stock (PHIO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Phio Pharmaceuticals Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Phio Pharmaceuticals Corp Shares that will get you 0.6912 shares as per Phio Pharmaceuticals Corp share price of $2.17 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Phio Pharmaceuticals Corp Stock (PHIO) from India?

Indian investors can start investing in Phio Pharmaceuticals Corp (PHIO) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 5:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Phio Pharmaceuticals Corp stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 5:40 am IST). Based on Phio Pharmaceuticals Corp share’s latest price of $2.17 as on September 17, 2025 at 1:29 am IST, you will get 4.6083 shares of Phio Pharmaceuticals Corp. Learn more about fractional shares .

What are the returns that Phio Pharmaceuticals Corp has given to Indian investors in the last 5 years?

Phio Pharmaceuticals Corp stock has given -91.71% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?